{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:13:34Z","timestamp":1792876414245,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Association Jules Bordet"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Two distinct histological growth patterns (HGPs) were described in patients with peritoneal metastasis of colorectal cancer origin (PMCRC) with limited Peritoneal Cancer Index (PCI) \u2264\u20096 who did not receive neoadjuvant chemotherapy (NAC) and were treated with cytoreductive surgery (CRS) \u00b1 hyperthermic intraperitoneal chemotherapy (HIPEC): pushing HGP (P-HGP) and infiltrating HGP (I-HGP). Patients with dominant P-HGP (&gt;\u200950%) had significantly better disease-free survival (DFS) and overall survival (OS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>We aimed to determine whether these previous observations regarding the prognostic value of HGP in patients with PMCRC with low PCI (\u2264\u20096) are also valid in all operable patients, regardless of whether they received NAC or not and regardless of PCI score.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective study including 76 patients who underwent complete CRS \u00b1 HIPEC for PMCRC between July 2012 and March 2019. In each patient, up to five of the largest excised peritoneal nodules were analyzed for their tumor-to-peritoneum interface. Correlations between NAC, HGP, and prognosis were further explored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-seven patients (49%) had dominant P-HGP and 39 (51%) had dominant I-HGP. On univariate analysis, patients with P-HGP \u2264\u200950% had significantly lower OS than those with dominant P-HGP &gt;\u200950% (39 versus 60 months; <jats:italic>p\u2009<\/jats:italic>=\u20090.014) confirmed on multivariate analysis (hazard ratio 2.4, 95% confidence interval 1.3\u20134.5; <jats:italic>p\u2009<\/jats:italic>=\u20090.006). There were no significant associations between NAC and type of HGP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study confirms the prognostic value and reproducibility of the two previously reported HGPs in PMCRC. Dominant P-HGP is associated with better DFS and OS in patients undergoing curative-intent CRS \u00b1 HIPEC compared with I-HGP, independently of the extent of peritoneal disease burden.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-024-15125-y","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T20:02:04Z","timestamp":1710532924000},"page":"3778-3784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Retrospective Evaluation of the Prognostic Value of Histological Growth Pattern in Patients with Colorectal Peritoneal Metastases Undergoing Curative-Intent Cytoreductive Surgery"],"prefix":"10.1245","volume":"31","author":[{"given":"Leonel","family":"Kamdem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine El","family":"Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Demetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael Coulibaly","family":"Zana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charif","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sclafani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Donckier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Liberale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"15125_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin."},{"key":"15125_CR2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1634\/theoncologist.12-7-825","volume":"12","author":"N Kemeny","year":"2007","unstructured":"Kemeny N. Presurgical chemotherapy in patients being considered for liver resection; presurgical chemotherapy in patients being considered for liver resection. Oncologist. 2007;12:825\u201339.","journal-title":"Oncologist."},{"key":"15125_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","volume":"244","author":"S Manfredi","year":"2006","unstructured":"Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254\u20139.","journal-title":"Ann Surg."},{"key":"15125_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejso.2015.11.011","volume":"42","author":"M Barat","year":"2016","unstructured":"Barat M, Soyer P, Eveno C, et al. The presence of cardiophrenic angle lymph nodes is not an indicator of peritoneal carcinomatosis from colorectal cancer on MDCT: results of a case-control study. Eur J Surg Oncol. 2016;42:266\u201372.","journal-title":"Eur J Surg Oncol."},{"key":"15125_CR5","unstructured":"Capussotti L, Ferrero A, Muratore A, et al. (2011) Surgical treatment of colorectal liver metastases. [Google books] 2011. Available at: https:\/\/books.google.be\/books?hl=en&lr=&id=W1C4oTEnKDAC&oi=fnd&pg=PR4&dq=Muratore+A,+Ribero+D,+Viganos+L+(2011)+Epidemiology+and+natural+history%3B+surgical+treatment+of+colorectal+liver+metastases.+Springer,+Milan,+pp+1-6&ots=LeW9moGYic&sig=PZcObJ8X4-1B7_Gok2C24TpLDt8&redir_esc=y#v=onepage&q&f=false. Accessed 29 Jan 2021."},{"key":"15125_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138.","journal-title":"J Clin Oncol."},{"key":"15125_CR7","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1245\/s10434-022-12736-1","volume":"30","author":"A El Asmar","year":"2023","unstructured":"El Asmar A, Delcourt M, Kamden L, et al. Prognostic value of preoperative serological biomarkers in patients undergoing curative-intent Cytoreductive surgery for colorectal cancer peritoneal metastases. Ann Surg Oncol. 2023;30:1863\u20139. https:\/\/doi.org\/10.1245\/s10434-022-12736-1.","journal-title":"Ann Surg Oncol."},{"key":"15125_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.annonc.2021.03.206","volume":"32","author":"A Grothey","year":"2021","unstructured":"Grothey A, Fakih M, Tabernero J. Management of BRAF-mutant metastatic colorectal cancer: A review of treatment options and evidence-based guidelines. Ann Oncol. 2021;32:959\u201367.","journal-title":"Ann Oncol."},{"key":"15125_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s004320000199","volume":"127","author":"R Lunevicius","year":"2001","unstructured":"Lunevicius R, Nakanishi H, Ito S, et al. Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer. J Cancer Res Clin Oncol. 2001;127:193\u20139.","journal-title":"J Cancer Res Clin Oncol."},{"key":"15125_CR10","first-page":"5185","volume":"32","author":"H Nystr\u00f6m","year":"2012","unstructured":"Nystr\u00f6m H, Naredi P, Berglund A, et al. Liver-metastatic potential of colorectal cancer is related to the stromal composition of the tumour. Anticancer Res. 2012;32:5185\u201391.","journal-title":"Anticancer Res."},{"key":"15125_CR11","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/modpathol.2014.4","volume":"27","author":"K Nielsen","year":"2014","unstructured":"Nielsen K, Rolff HC, Eefsen RL, et al. The morphological growth patterns of colorectal liver metastases are prognostic for overall survival. Mod Pathol. 2014;27:1641\u20138.","journal-title":"Mod Pathol."},{"key":"15125_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/1097-0142(20000715)89:2<267::AID-CNCR10>3.0.CO;2-1","volume":"89","author":"K Okano","year":"2000","unstructured":"Okano K, Yamamoto J, Kosuge T, et al. Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma: Clinicopathologic study of 152 first resection cases. Cancer. 2000;89:267\u201375.","journal-title":"Cancer."},{"key":"15125_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10585-012-9469-1","volume":"29","author":"GG Van Den Eynden","year":"2012","unstructured":"Van Den Eynden GG, Bird NC, Majeed AW, et al. The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis. 2012;29:541\u20139.","journal-title":"Clin Exp Metastasis."},{"key":"15125_CR14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1007\/s00268-002-6267-y","volume":"26","author":"J Yamaguchi","year":"2002","unstructured":"Yamaguchi J, Komuta K, Matsuzaki S, et al. Mode of infiltrative growth of colorectal liver metastases is a useful predictor of recurrence after hepatic resection. World J Surg. 2002;26:1122\u20135.","journal-title":"World J Surg."},{"key":"15125_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1572-0241.1999.00945.x","volume":"94","author":"I Nagashima","year":"1999","unstructured":"Nagashima I, Oka T, Hamada C, et al. Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer. Am J Gastroenterol. 1999;94:739\u201343.","journal-title":"Am J Gastroenterol."},{"key":"15125_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.amjsurg.2013.05.015","volume":"207","author":"RS Pinheiro","year":"2014","unstructured":"Pinheiro RS, Herman P, Lupinacci RM, et al. Clinical science tumor growth pattern as predictor of colorectal liver metastasis recurrence. Am J Surg. 2014;207:493\u20138.","journal-title":"Am J Surg."},{"key":"15125_CR17","doi-asserted-by":"publisher","first-page":"6280347","DOI":"10.1155\/2019\/6280347","volume":"2019","author":"RC Oliveira","year":"2019","unstructured":"Oliveira RC, Alexandrino H, Cipriano MA, et al. Liver metastases and histological growth patterns: Biological behavior and potential clinical implications-another path to individualized medicine? J Oncol. 2019;2019:6280347.","journal-title":"J Oncol."},{"key":"15125_CR18","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1245\/s10434-023-13118-x","volume":"30","author":"A El Asmar","year":"2023","unstructured":"El Asmar A, Demetter P, Fares F, et al. The prognostic value of distinct histological growth patterns of colorectal peritoneal metastases: A pilot study. Ann Surg Oncol. 2023;30:3320\u20138. https:\/\/doi.org\/10.1245\/s10434-023-13118-x.","journal-title":"Ann Surg Oncol."},{"key":"15125_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10456-019-09661-5","volume":"22","author":"B Galjart","year":"2019","unstructured":"Galjart B, Nierop PMH, van der Stok EP, et al. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases. Angiogenesis. 2019;22:355\u201368.","journal-title":"Angiogenesis."},{"issue":"10","key":"15125_CR20","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/bjc.2017.334","volume":"117","author":"PJ Van Dam","year":"2017","unstructured":"Van Dam PJ, Van Der Stok EP, Teuwen LA, Van den Eynden GG, Illemann M, Frentzas S, Majeed AW, Eefsen RL, Coebergh van den Braak RR, Lazaris A, Fernandez MC, et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. Br j cancer. 2017;117(10):1427\u201341.","journal-title":"Br j cancer."},{"key":"15125_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/cjp2.235","volume":"8","author":"PMH Nierop","year":"2022","unstructured":"Nierop PMH, H\u00f6ppener DJ, Buisman FE, et al. Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases. J Pathol Clin Res. 2022;8:48\u201364.","journal-title":"J Pathol Clin Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15125-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15125-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15125-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T13:08:42Z","timestamp":1715087322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15125-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["15125"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15125-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"assertion":[{"value":"2 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Leonel Kamdem, Antoine El Asmar, Pieter Demetter, Ismael Coulibaly Zana, Charif Khaled, Francesco Sclafani, Vincent Donckier, Peter Vermeulen, and Gabriel Liberale declare they have no conflicts of interest in relation to this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}